Q4 2021 Holdings
Filed 2022-02-14 | 68 holdings | $57.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $44 | 10,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $230 | 13,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $456 | 7,800 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $769 | 64,585 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.1K | 231,485 | 0.0% |
| Avalo Therapeutics Inc | COM | 05338F108 | $1.3K | 770,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $1.4K | $1,950,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.7K | 22,000 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.7K | 22,275 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $1.7K | 175,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.8K | 90,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $2.5K | 68,320 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $2.5K | 158,700 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $2.6K | 687,412 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $2.8K | 175,152 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $3.0K | 300,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.4K | 1,644,500 | 0.0% |
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $3.4K | 350,000 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $3.6K | 86,180 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $3.7K | 40,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.0K | 338,760 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.2K | 7,759 | 0.0% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $4.3K | 672,734 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $4.4K | 51,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.9K | 298,700 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $5.0K | 310,494 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $5.2K | 427,200 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.4K | 98,800 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $6.1K | 101,600 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $6.3K | 27,450 | 0.0% |
| Sientra Inc | COM | 82621J105 | $6.9K | 1,891,878 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.0K | 294,750 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.6K | 477,495 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $8.2K | 1,258,889 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.8K | 378,997 | 0.0% |
| Steris PLC(STE) | SHS USD | G8473T100 | $12.7K | 52,100 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $14.2K | 138,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $16.0K | 228,437 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $17.9K | 1,068,376 | 0.0% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $18.5K | 1,999,087 | 0.0% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $18.9K | 3,148,609 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $19.3K | 2,295,100 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $20.5K | 810,940 | 0.0% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $20.5K | 593,200 | 0.0% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $20.8K | 450,030 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $21.3K | 227,599 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $21.5K | 743,238 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $21.9K | 1,550,497 | 0.0% |
| Neuropace Inc(NPCE) | COM | 641288105 | $23.3K | 2,309,003 | 0.0% |
| Theratechnologies Inc | COM | 88338H100 | $23.3K | 7,692,082 | 0.0% |